Cybin D/B/A Helus Pharma HELP
Set alert
10.60 USD -0.12 -1.07%
At close
10.76 +0.16 +1.56%
Pre-market · Nov 2, 4:57 AM ET
10.42 Day range 10.97
3.76 52-week range 15.15
- YTD
- +29.52%
- 1 year
- +45.94%
- Open
- 10.53
- Prev close
- 10.71
- Mkt cap
- 774.07M
- Vol
- 1.15M
- Avg vol
- 1.70M
- EPS
- -4.15
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 10.42
- High
- 10.97
- Forward P/E
- -7.55
- Beta
- 0.63
- Short ratio
- 1.59
- Inst. own
- 41.29%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 12, 2026
- 50-d avg
- 10.70
- 200-d avg
- 7.11
- 1y target
- 40.24
5Y chart
Events in this range
- Aug 13, 2025Earnings: -1.09874; estimate -0.95779; surprise -14.72%
- Nov 13, 2025Earnings: -1.39; estimate -0.74; surprise -87.84%
- Feb 13, 2026Earnings: -0.99243; estimate -0.53; surprise -87.25%
- Apr 13, 2026Rating: TD Cowen · — → Buy
- Jun 30, 2026Earnings: -0.95583; estimate -1.04; surprise 8.09%
- Jul 1, 2026Rating: Canaccord Genuity · Buy → Buy
- Jul 9, 2026Rating: HC Wainwright & Co. · Buy → Buy
- Jul 27, 2026Rating: Wells Fargo · — → Overweight
- Aug 14, 2026Earnings: -0.91; estimate -0.83607; surprise -8.84%
- Aug 20, 2026Rating: TD Cowen · Buy → Buy
- Sep 18, 2026Rating: Barclays · — → Overweight
Signals (95)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 19, 2026 | 2 weeks ago |
| SMA: Bearish | Sep 28, 2026 | 1 month ago |
| RSI: Overbought | Aug 3, 2026 | 3 months ago |
| SMA: Bullish | Jun 22, 2026 | 4 months ago |
| SMA: Bullish | Jun 22, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 22, 2026 | 4 months ago |
| SMA: Bearish | May 11, 2026 | 5 months ago |
| SMA: Bullish | May 4, 2026 | 6 months ago |
| SMA: Bearish | Apr 27, 2026 | 6 months ago |
| SMA: Bullish | Apr 20, 2026 | 6 months ago |
| SMA: Bearish | Mar 2, 2026 | 8 months ago |
| SMA: Bearish | Mar 2, 2026 | 8 months ago |
| MACD: Sell Signal | Mar 2, 2026 | 8 months ago |
| SMA: Bullish | Feb 23, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 23, 2026 | 8 months ago |
| SMA: Bullish | Feb 16, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 9, 2026 | 8 months ago |
| SMA: Bearish | Jan 26, 2026 | 9 months ago |
| SMA: Bearish | Jan 26, 2026 | 9 months ago |
| SMA: Bullish | Dec 15, 2025 | 10 months ago |
| SMA: Bullish | Dec 8, 2025 | 10 months ago |
| SMA: Bearish | Dec 1, 2025 | 11 months ago |
| SMA: Bullish | Nov 24, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 24, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 17, 2025 | 11 months ago |
| SMA: Bearish | Nov 3, 2025 | 12 months ago |
| SMA: Bearish | Nov 3, 2025 | 12 months ago |
| SMA: Bullish | Oct 27, 2025 | 1 year ago |
| SMA: Bullish | Oct 27, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 27, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 1, 2025 | 1 year ago |
| SMA: Bearish | Jul 21, 2025 | 1 year ago |
| SMA: Bearish | Jul 21, 2025 | 1 year ago |
| SMA: Bullish | Jul 14, 2025 | 1 year ago |
| SMA: Bullish | Jul 14, 2025 | 1 year ago |
| SMA: Bearish | Jul 7, 2025 | 1 year ago |
| SMA: Bearish | Jun 9, 2025 | 1 year ago |
| SMA: Bullish | Jun 2, 2025 | 1 year ago |
| SMA: Bullish | May 19, 2025 | 1 year ago |
| MACD: Buy Signal | May 19, 2025 | 1 year ago |
| SMA: Bearish | May 12, 2025 | 1 year ago |
| SMA: Bullish | May 5, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 24, 2025 | 1 year ago |
| SMA: Bearish | Feb 17, 2025 | 1 year ago |
| SMA: Bullish | Feb 10, 2025 | 1 year ago |
| SMA: Bearish | Feb 3, 2025 | 1 year ago |
| SMA: Bearish | Jan 27, 2025 | 1 year ago |
| SMA: Bullish | Jan 20, 2025 | 1 year ago |
| SMA: Bullish | Jan 20, 2025 | 1 year ago |
| SMA: Bearish | Dec 9, 2024 | 1 year ago |
| SMA: Bearish | Dec 9, 2024 | 1 year ago |
| SMA: Bullish | Dec 2, 2024 | 1 year ago |
| SMA: Bullish | Nov 25, 2024 | 1 year ago |
| SMA: Bearish | Nov 18, 2024 | 1 year ago |
| SMA: Bearish | Nov 18, 2024 | 1 year ago |
| SMA: Bullish | Nov 11, 2024 | 1 year ago |
| SMA: Bearish | Oct 21, 2024 | 2 years ago |
| SMA: Bullish | Oct 14, 2024 | 2 years ago |
| SMA: Bullish | Oct 7, 2024 | 2 years ago |
| SMA: Bearish | Sep 30, 2024 | 2 years ago |
| MACD: Buy Signal | Sep 30, 2024 | 2 years ago |
| SMA: Bullish | Sep 23, 2024 | 2 years ago |
| RSI: Oversold | Sep 9, 2024 | 2 years ago |
| SMA: Bearish | Jul 15, 2024 | 2 years ago |
| SMA: Bullish | Jul 8, 2024 | 2 years ago |
| MACD: Sell Signal | Apr 22, 2024 | 2 years ago |
| SMA: Bearish | Apr 8, 2024 | 2 years ago |
| SMA: Bearish | Mar 18, 2024 | 2 years ago |
| SMA: Bullish | Mar 11, 2024 | 2 years ago |
| MACD: Buy Signal | Mar 11, 2024 | 2 years ago |
| SMA: Bullish | Mar 4, 2024 | 2 years ago |
| SMA: Bearish | Dec 18, 2023 | 2 years ago |
| MACD: Sell Signal | Nov 27, 2023 | 2 years ago |
| SMA: Bearish | Nov 6, 2023 | 2 years ago |
| SMA: Bullish | Sep 18, 2023 | 3 years ago |
| SMA: Bullish | Sep 18, 2023 | 3 years ago |
| SMA: Bearish | Jul 31, 2023 | 3 years ago |
| SMA: Bearish | Jul 31, 2023 | 3 years ago |
| SMA: Bullish | Jun 26, 2023 | 3 years ago |
| SMA: Bullish | Jun 26, 2023 | 3 years ago |
| MACD: Buy Signal | Jun 26, 2023 | 3 years ago |
| MACD: Sell Signal | May 8, 2023 | 3 years ago |
| SMA: Bearish | Mar 6, 2023 | 3 years ago |
| MACD: Buy Signal | Jan 9, 2023 | 3 years ago |
| SMA: Bullish | Jan 2, 2023 | 3 years ago |
| RSI: Oversold | Dec 12, 2022 | 3 years ago |
| MACD: Sell Signal | Oct 17, 2022 | 4 years ago |
| SMA: Bearish | Sep 12, 2022 | 4 years ago |
| SMA: Bearish | Sep 12, 2022 | 4 years ago |
| SMA: Bullish | Aug 8, 2022 | 4 years ago |
| SMA: Bullish | Aug 1, 2022 | 4 years ago |
| SMA: Bearish | Jul 11, 2022 | 4 years ago |
| SMA: Bullish | Jul 4, 2022 | 4 years ago |
| SMA: Bearish | Jun 13, 2022 | 4 years ago |
| SMA: Bullish | May 30, 2022 | 4 years ago |
Financial health
Altman Z-Score
27.56 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 4
Valuation
P/E -1.1×
FY 2017 5y median -1.1× FY 2026
P/S -3.7×
FY 2017 5y median 155× FY 2026
P/B 0.7×
FY 2017 5y median 0.7× FY 2026
P/FCF -1.2×
FY 2017 5y median -1.2× FY 2026
EV/EBITDA -0.1×
FY 2017 5y median -0.1× FY 2026
EV/Sales -0.2×
FY 2017 5y median 0.0× FY 2026
FCF Yield -80.1%
FY 2017 5y median -80.1% FY 2026
Profitability
Gross Margin 100.3%
FY 2017 5y median 0.0% FY 2026
Operating Margin 317.1%
FY 2017 5y median -20523.9% FY 2026
Net Margin 329.1%
FY 2017 5y median -18919.2% FY 2026
ROE -63.3%
FY 2017 5y median -63.3% FY 2026
ROIC -60.9%
FY 2017 5y median -60.9% FY 2026
ROA -58.4%
FY 2017 5y median -58.4% FY 2026
Growth (YoY)
Revenue -9561.6%
FY 2017 FY 2026
Operating Income 1.0%
FY 2017 FY 2026
EPS (diluted) 24.3%
FY 2017 FY 2026
Free Cash Flow -29.6%
FY 2017 FY 2026
Financial Health
Current Ratio 9.5×
FY 2017 5y median 7.7× FY 2026
Quick Ratio 9.5×
FY 2017 5y median 7.7× FY 2026
Debt / Equity 0.0×
FY 2017 5y median 0.0× FY 2026
Net Debt / EBITDA 1.1×
FY 2017 5y median 0.9× FY 2026
Interest Coverage 0.0×
FY 2017 5y median 0.0× FY 2026
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2026
Annual · latest fiscal year ends 2026-03-31